Bonavita E. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain. Int J Clin Pharmacol Ther Toxicol. 1986;24(9):511-6.
Fietta P, Manganelli P. Carnitine: a therapeutic option for childhood psoriatic oncho-pachydermo-periostitis (POPP). Clin Rheumatol 2007;26:93-94.
Giamberardino MA, et al. Effects of prolonged L-Carnitine administration on delayed muscle pain and CK release after eccentric effort. Int J Sports Med 1996;17(5):320-24.
Leibovitz B., Mueller J. Carnitine. Journal of Optimal Nutrition 1993; 2: 90-109. Lohninger A, Kaiser E, Legenstein E, Staniek H: Carnitine, metabolism and function; In: Kaiser E. Carnitine: Its Role in Lung and Heart Disorder 1987.
Malaguarnera M, Cammalleri L, Gargante MP, et al. L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial. Am J Clin Nutr. 2007;86(6):1738-44.
Shen W, Liu K, Tian C, et al. R-a-Lipoic acid and acetyl-L-carnitine complementarily promote mitochondrial biogenesis in murine 3T3-L1 adipocytes. Diabetologia 2008;51(1):165-74.
Sima AA, Calvani M, Mehra M, Amato A; Acetyl-L-Carnitine Study Group. Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials. Diabetes Care. 2005;28(1):89-94.
Tomassini V, Pozzilli C, Onesti E, et al. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial. J Neurol Sci. 2004;218(1-2):103-8.
